Tender Details

Country: USA
Summary: Radio Frequency Therapy System for WACH
UST Ref No: 122910405
Deadline: 22 Jul 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: W81K0025QA150
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
Clinical Efficacy and Performance.

Ablation Success Rates: Documented amenorrhea rates (e.g.,50-60%) and a significant reduction in bleeding (e.g.,90% patient satisfaction) at 12 months post-procedure from clinical trials or post-market surveillance.

Treatment Time: Short, standardized procedure time (e.g., typically
Uterine Cavity Compatibility: Stated range of uterine lengths (e.g., 6-10 cm, or 8-12 cm) and fundal width accommodation (e.g., by expandable array). Ensures applicability to a broad range of patients without requiring multiple specialized probes, reducing inventory and ensuring more patients are eligible (e.g., 4-6mm) across the entire endometrial surface, including cornual regions, as confirmed by histology or follow-up. Importance: reduced risk of incomplete alation, persistent bleeding, and need for repeat procedure.

End-point Detection: Automatic system shut-off based on reaching specific internal parameters (e.g., impedance rise, temperature plateau, complete energy delivery) that indicate successful ablation. Endures consistent, complete ablation while preventing overtreatment and relies less on user judgment, improving consistency across multiple gynecologists.

Real-time Monitoring and Feedback: Continuous, real-time display of critical parameters such as intrauterine temperature, pressure (if balloon-based), and impedance. Allows immediate detection of potential issues (e.g., perforation, inadequate tissue contact) and endures optimal ablation. System automatically terminates energy delivery and provides distinct auditory/visual alarms for abnormal conditions (e.g., uterine perforation/pressure drop, excessive temperature, high impedance, low tissue contact, power surges0. Prevents patient injury and ensures a safe procedure even with varying user experience.

Intuitive user Interface: Touchscreen interface with clear, guided prompts; minimal steps for setup and operation; singl...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Radio Frequency Therapy System for WACH - USA Tender

The DEPT OF DEFENSE | DEPT OF THE ARMY, a Government sector organization in USA, has announced a new tender for Radio Frequency Therapy System for WACH. This tender is published on USARFP under UST Ref No: 122910405 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-22.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.